Breaking News
Get 60% Off 0
Cyber Monday Deal: Up to 60% off InvestingPro
CLAIM SALE

Fisher & Paykel Healthcare stock rated Neutral by UBS, sees growth driven by HFT adoption

Published Nov 29, 2024 05:52
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
FPH
+0.84%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

On Friday, UBS updated its price target for Fisher & Paykel Healthcare (FPH:NZ) (OTC: FSPKF), lifting it to NZD38.10, up from the previous NZD36.00. Despite the increase, the firm has decided to maintain a Neutral rating on the stock. The adjustment reflects UBS's view of the company's anticipated earnings growth and its position in the market.

According to UBS, Fisher & Paykel Healthcare's share price accurately represents the company's strong earnings per share (EPS) growth, which is expected to continue at a compound annual growth rate (CAGR) of 25% from the 2025 fiscal year onwards. This growth trajectory is attributed to the increasing adoption of high flow therapy (HFT), gains in the obstructive sleep apnea (OSA) mask market share, and anticipated margin expansion.

The analyst from UBS highlighted that the wider utilization of HFT in hospitals is likely to be bolstered by the ongoing 'COVID halo effect' and the enhanced patient benefits delivered by new product offerings. Furthermore, it is expected that Fisher & Paykel Healthcare will retain a price-to-earnings (P/E) premium approximately 50% higher than that of its Australasia (ANZ) large-cap healthcare peers, due to its superior EPS growth prospects.

Looking ahead, UBS suggests that any potential upside in Fisher & Paykel Healthcare's share price could stem from a valuation based on higher future EPS or from the opportunities presented by the home HFT market. The latter, according to UBS's estimates, could contribute an additional value of $3-5 per share to the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Fisher & Paykel Healthcare stock rated Neutral by UBS, sees growth driven by HFT adoption
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email